Related Experiment Videos
Hypercalcemia in atypical bronchial carcinoid tumors
Chest
|November 1, 1989
Summary
Atypical bronchial carcinoid tumors can cause hypercalcemia and osteolytic bone metastases, even after surgery. Chemotherapy may effectively treat these rare but serious complications.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Atypical carcinoid tumors (ACTs) are rare neuroendocrine neoplasms of the bronchial tree.
- ACTs characteristically metastasize to bone, typically causing osteoblastic lesions.
- Calcium homeostasis is usually maintained despite bone metastases.
Observation:
- Two patients with ACTs presented with hypercalcemia and osteolytic bone metastases post-surgery.
- This presentation contrasts with the typical osteoblastic, normocalcemic metastatic pattern.
Findings:
- The patients exhibited hypercalcemia and osteolytic bone lesions, indicating an unusual metastatic behavior.
- In one case, chemotherapy led to remission of the cancer and resolution of hypercalcemia.
Implications:
- This case series highlights a rare but severe complication of atypical bronchial carcinoid tumors.
- It suggests that osteolytic metastases and hypercalcemia should be considered in patients with a history of ACTs.
- Chemotherapy may be a viable treatment option for managing hypercalcemia and metastatic disease in these patients.